Skip to main content
. 2024 Feb 20;30:1611497. doi: 10.3389/pore.2024.1611497

FIGURE 1.

FIGURE 1

Distribution of patients newly receiving first-line treatment for CML between 2011 and 2019 according to type of TKI. CML, chronic myeloid leukemia; TKI, tyrosine kinase inhibitor. N/A, not applicable (NHIF does not provide data with patient numbers below 10).